Merck’s Prevymis Set To Expand Into Renal Transplant CMV Prevention
Possible New Option
The major’s antiviral has hit the mark in a late-stage study of CMV disease prevention in the post kidney transplant setting, triggering plans for a US filing to expand its indication from stem cell transplant patients.
